Uremic men may manifest a variety of hormonal abnormalities, including
decreased serum concentrations of testosterone and thyroid hormones a
nd increased serum levels of growth hormone and prolactin. Some previo
us investigations have reported that erythropoietin therapy may revers
e these hormonal changes. To investigate this possibility further, we
measured serum prolactin, testosterone, LH, FSH, TSH, free thyroxine,
triiodothyronine, growth hormone and IGF-I in 21 generally elderly mal
e hemodialysis patients before and during erythropoietin therapy; many
of the patients also received an anabolic steroid or metoclopramide t
reatment. Despite a significant erythropoietic response in a majority
of the subjects, no significant changes were seen in any of the hormon
al parameters other than a small decrease in serum growth hormone conc
entrations. Advanced age and chronic illness in our patients may have
played a role in limiting the hormonal response reported by others.